BackgroundCheck.run
Search For

James J Treanor, 63Toms River, NJ

Known as:
Jim J Treanor Jim Treaner
Related to:
Shannon M Lavin 53 Michael Williams 69 Hazel Williams 62 Anthony Williams 64 Jennifer Williams 51 William White

James Treanor Phones & Addresses

Toms River, NJ   

610 Pitney Pl, Morristown, NJ 07960    973-5395302   

Glendale, CA   

Canton, NY   

Maplewood, NJ   

Plattsburgh, NY   

Taylorsville, UT   

333 Elmwood Ave APT M466, Maplewood, NJ 07040    973-5383309   

Social networks

James J Treanor

Linkedin

Work

Company: Cadwalader, Wickersham & Taft LLP Address:
Get Report
Control this profile

Mentions for James J Treanor

Career records & work history

Lawyers & Attorneys

James Treanor Photo 1

James A. Treanor - Lawyer

Licenses:
New York - Currently registered 1966
Education:
Fordham University School of Law
James Treanor Photo 2

James J Treanor, Toms River NJ - Lawyer

Address:
Toms River, NJ
732-2287996 (Office)
Licenses:
New Jersey - Active 1991
James Treanor Photo 3

James Joseph Treanor, Toms River NJ - Lawyer

Address:
Law Office of James J Treanor, LLC
200 Main St Ste 105, Toms River, NJ 08753
732-2287996 (Office)
Licenses:
New York - Currently registered 1992
Education:
Cornell
James Treanor Photo 4

James Treanor - Lawyer

Office:
Cadwalader, Wickersham & Taft LLP
Specialties:
Anti-Money Laundering Investigations and Compliance, Cybersecurity and Data Protection, Economic Sanctions, FCPA Enforcement and Compliance, False Claims Act and Health Care Fraud, Global Litigation, National Security, Pharmaceutical Regulation and Compliance, Securities Enforcement and Compliance, White Collar Defense and Investigations
ISLN:
920821488
Admitted:
2010
University:
University of Pennsylvannia, B.A., 2003; Georgetown University, M.A., 2006
Law School:
George Washington University Law School, J.D., 2009

James Treanor resumes & CV records

Resumes

James Treanor Photo 34

James Treanor

Publications & IP owners

Us Patents

Human Anti-Ngf Neutralizing Antibodies As Selective Ngf Pathway Inhibitors

US Patent:
2009015, Jun 18, 2009
Filed:
Nov 25, 2008
Appl. No.:
12/277919
Inventors:
James J.S. Treanor - Sherman Oaks CA, US
Haichun Huang - Fremont CA, US
Heather Inoue - Oak Park CA, US
Tie J. Zhang - Thousand Oaks CA, US
Frank Martin - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
MEDAREX, INC. - Princeton NJ
International Classification:
A61K 39/395
C07K 16/18
US Classification:
4241351, 4241301, 5303873
Abstract:
This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided.

Human Anti-Ngf Neutralizing Antibodies As Selective Ngf Pathway Inhibitors

US Patent:
2010003, Feb 11, 2010
Filed:
Oct 9, 2009
Appl. No.:
12/576522
Inventors:
James J.S. Treanor - Sherman Oaks CA, US
Haichun Huang - Fremont CA, US
Heather Inoue - Oak Park CA, US
Tie J. Zhang - Thousand Oaks CA, US
Frank Martin - Newbury Park CA, US
Assignee:
AMGEN, INC. - Thousand Oaks CA
MEDAREX, INC. - Princeton NJ
International Classification:
A61K 39/395
US Classification:
4241331, 4241301
Abstract:
This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided.

Human Anti-Ngf Neutralizing Antibodies As Selective Ngf Pathway Inhibitors

US Patent:
2011004, Feb 17, 2011
Filed:
Aug 18, 2010
Appl. No.:
12/859246
Inventors:
James J.S. Treanor - Sherman Oaks CA, US
Haichun Huang - Fremont CA, US
Heather Inoue - Oak Park CA, US
Tie J. Zhang - Thousand Oaks CA, US
Frank Martin - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
MEDAREX, INC. - Princeton NJ
International Classification:
C07K 16/22
US Classification:
5303879, 53038824, 53038815
Abstract:
This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided.

Human Anti-Ngf Neutralizing Antibodies As Selective Ngf Pathway Inhibitors

US Patent:
2011009, Apr 21, 2011
Filed:
Sep 13, 2010
Appl. No.:
12/880961
Inventors:
James J.S. Treanor - Sherman Oaks CA, US
Haichun Huang - Fremont CA, US
Heather Inoue - Oak Park CA, US
Tie J. Zhang - Thousand Oaks CA, US
Frank Martin - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
MEDAREX, INC. - Princeton NJ
International Classification:
A61K 39/395
C12N 5/10
C12N 15/63
G01N 33/566
C07K 16/22
C07H 21/04
A61P 19/02
US Classification:
4241581, 435358, 4353201, 436501, 5303871, 536 2353
Abstract:
This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided.

Tau Aggregation Peptide Inhibitors

US Patent:
2020021, Jul 9, 2020
Filed:
Aug 20, 2018
Appl. No.:
16/637567
Inventors:
- Thousand Oaks CA, US
Ashley Wrght - Los Angeles CA, US
James Treanor - Lake Sherwood CA, US
Marcin Apostol - Malibu CA, US
Matthew A.G. Graf - Ventura CA, US
International Classification:
C07K 7/06
G01N 33/68
Abstract:
This invention relates to the field of tau aggregation inhibitors. More specifically, the invention relates to amyloid therapeutics. More specifically, the invention provides pharmaceutical compositions and methods of treating aggregation associated conditions or diseases with certain peptides.

Peptide Inhibitors Of Transcription Factor Aggregation

US Patent:
2020006, Feb 27, 2020
Filed:
Feb 23, 2018
Appl. No.:
16/487381
Inventors:
- Thousand Oaks CA, US
Ashley Wright - Los Angeles CA, US
James Treanor - Lake Sherwood CA, US
Marcin Apostol - Malibu CA, US
International Classification:
C07K 7/06
C07K 14/47
Abstract:
This invention relates to materials, such as peptides, and methods to inhibit the aggregation transcription factors, for example p53 inhibitors, p63 inhibitors and p73 inhibitors. More specifically, the invention relates to cancer chemotherapeutics. More specifically, the invention provides pharmaceutical compositions and methods of treating cancer with certain peptides.

Possible Relatives

David L Treanor  Dean Treanor  Daniel P Treanor  Deeann E Treanor  Dave Treanor  Edward F Treanor  Elizabeth P Treanor  James V Johnson  James C Stamps  James E Stanage 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.